Abstract
Abstract
Background
The steep rise in substance use and substance use disorder (SUD) shows an urgency to assess its prevalence using valid measures. This systematic review summarizes the validity of measures to assess the prevalence of substance use and SUD in the US estimated in population and sub-population-based surveys.
Methods
A literature search was performed using nine online databases. Studies were included in the review if they were published in English and tested the validity of substance use and SUD measures among US adults at the general or sub-population level. Independent reviews were conducted by the authors to complete data synthesis and assess the risk of bias.
Results
Overall, 46 studies validating substance use/SUD (n = 46) measures were included in this review, in which 63% were conducted in clinical settings and 89% assessed the validity of SUD measures. Among the studies that assessed SUD screening measures, 78% examined a generic SUD measure, and the rest screened for specific disorders. Almost every study used a different survey measure. Overall, sensitivity and specificity tests were conducted in over a third of the studies for validation, and 10 studies used receiver operating characteristics curve.
Conclusion
Findings suggest a lack of standardized methods in surveys measuring and reporting prevalence of substance use/SUD among US adults. It highlights a critical need to develop short measures for assessing SUD that do not require lengthy, time-consuming data collection that would be difficult to incorporate into population-based surveys assessing a multitude of health dimensions.
Systematic review registration
PROSPERO CRD42022298280.
Funder
West Virginia Department of Health and Human Resources
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health. Rockville, MD; 2022. Report No.: HHS Publication No. PEP22–07–01–005.
2. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2022.
3. Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, Dickinson J, et al. National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf. 2008;17(12):1142–54.
4. Kacha-Ochana A, Jones C, Green J, Dunphy C, Dailey T, Robbins R, et al. Characteristics of adults aged ≥18 years evaluated for substance use and treatment planning - United States, 2019. MMWR Morb Mortal Wkly Rep. 2022;71:749–56.
5. Tiet QQ, Leyva YE, Moos RH, Smith B. Diagnostic accuracy of a two-item Drug Abuse Screening Test (DAST-2). Addict Behav. 2017;74:112–7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献